医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

UL Among High-Level Speakers at China-U.S. Occupational Health Symposium

2016年07月11日 PM11:00
このエントリーをはてなブックマークに追加


 

FRANKLIN, Tenn.

UL EHS Sustainability, the industry’s leading provider of workplace health, safety, and sustainability solutions, is among the invited speakers at the second China-U.S. Occupational Health Symposium from July 12-13 in Guangzhou, China. The event, hosted by the American Industrial Hygiene Association (AIHA) and the National Center for International Cooperation in Work Safety, SAWS (NCICS), will gather an elite group of health and safety leaders from multinational organizations and Chinese institutions to discuss pressing issues in occupational health and safety, best practices for messaging and reporting, and concerns specific to the Chinese market.

“China has been undergoing a period of dynamic economic growth, unparalleled in the world,” said Mark Ward, vice president and general manager of UL EHS Sustainability. “As the country continues to diversify its economy, expand its workforce, and drive global economics, health in the workplace will continue to be a pressing topic. This symposium brings together leading voices in the international and Chinese business community to share best practices, drill down on emerging areas of concern, and explore how a consistent occupational health program can increase productivity and profitability.”

The roundtable marks an important step in broadening UL’s global health and safety message and further realizing UL’s mission of working for a safer world.

“UL has been a leader in global science safety for more than 120 years, keeping products and workers safe throughout the world,” said Boris Feng, vice president and managing director of UL Greater China. “China’s unique business environment provides an opportunity for Chinese professionals to explore best practices and learn more about special challenges in their specific market. We look forward to building these relationships and learning more about how we can collaborate to keep Chinese workers safe and healthy.”

For more information about UL EHS Sustainability, call 888-202-3016 or visit ulehssustainability.com.

About UL

UL is a premier global independent safety science company that has championed progress for 120 years. Its more than 10,000 professionals are guided by the UL mission to promote safe working and living environments for all people. UL uses research and standards to continually advance and meet ever-evolving safety needs. We partner with businesses, manufacturers, trade associations and international regulatory authorities to bring solutions to a more complex global supply chain. For more information about our certification, testing, inspection, advisory and education services, visit http://www.ul.com.

About UL EHS Sustainability

UL EHS Sustainability (formerly UL Workplace Health and Safety) is a division of Underwriters Laboratories (‘UL’), the premier global independent safety science company that has championed progress for 120 years. In 2016, UL EHS Sustainability acquired cr360, a leader in Sustainability and EHS management software. UL EHS Sustainability empowers organizations to protect the well-being of workers, reduce risk, improve productivity, enhance compliance, and drive measurable business improvement through its EHS, occupational health, environmental, supply chain, sustainability, and corporate social responsibility platforms. Thousands of organizations in over 20 major industries including manufacturing, healthcare, and construction & energy, trust UL’s tools to meet their expanding needs. To learn more, visit www.ULEHSS.com or call 888.202.3016.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160711005213/en/

CONTACT

Arketi Group
Erin Sikorski, 404-929-0091 x208
esikorski@arketi.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • Shinkowa Pharmaceutical Co., Ltd., Distributor of the World’s First Supplements Containing β-Nicotinamide Mononucleotide (NMN), Has Begun World-Wide Distribution of the Special Products “NMN PURE 3000″ and “NMN PURE 1500″
  • Interim Analysis of Ignyta’s Entrectinib Suggests Potential Best-in-Class Profile as a First-Line Targeted Therapy in Patients With ROS1-Positive Non-Small Cell Lung Cancer
  • Spectrum Pharmaceuticals Highlights Poziotinib Data in Non-Small-Cell Lung Cancer (NSCLC) Presented at the 18th IASLC World Conference on Lung Cancer in Japan
  • 武田呈报ALUNBRIGTM (brigatinib)治疗ALK阳性非小细胞肺癌枢纽性2期ALTA试验的更新结果
  • GenePeeks Expands Distribution to India with Exclusive Agreement with CORE Diagnostics